Asian Journal of Pharmaceutical Sciences

Papers
(The H4-Index of Asian Journal of Pharmaceutical Sciences is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Artificial polysaccharide-binding protein mediates co-assembly of nanodrug and probiotics against drug-resistant infectious enteritis153
Ginseng-derived exosome-like nanovesicles protect against liver fibrosis by regulating TIMP2 pathways and gut dysbiosis100
Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment87
CaCO3-encircled hollow CuS nanovehicles to suppress cervical cancer through enhanced calcium overload-triggered mitochondria damage74
Spatiotemporal transformable nano-assembly for on-demand drug delivery to enhance anti-tumor immunotherapy53
Recent advances in cell membrane-based biomimetic delivery systems for Parkinson’s disease: Perspectives and challenges48
Charge adaptive phytochemical-based nanoparticles for eradication of methicillin-resistant staphylococcus aureus biofilms36
Versatile applications of deep eutectic solvents in drug discovery and drug delivery systems: Perspectives and opportunities36
Penetrative biomimetic nanovehicle boosts immunotherapy in triple-negative breast cancer via SOS1 blockade33
Hyaluronic acid conjugates with controlled oleic acid substitution as new nanomaterials for improving ocular co-delivery of cyclosporine A and oleic acid33
Bone mesenchymal stem cell-derived exosomes involved co-delivery and synergism effect with icariin via mussel-inspired multifunctional hydrogel for cartilage protection33
Ferroptosis-induced anticancer effect of resveratrol with a biomimetic nano-delivery system in colorectal cancer treatment31
Cell membrane-coated mRNA nanoparticles for enhanced delivery to dendritic cells and immunotherapy29
Improving treatment for Parkinson's disease: Harnessing photothermal and phagocytosis-driven delivery of levodopa nanocarriers across the blood-brain barrier28
pH-activatable oxidative stress amplifying dissolving microneedles for combined chemo-photodynamic therapy of melanoma27
Structure based release kinetics analysis of doxazosin mesylate sustained-release tablets using micro-computed tomography27
Targeted delivery of glucocerebrosidase to lysosomes: The LYSOTAC (LYSOsome-TArgeting Chimera) technology27
Comparison of virus-capsid mimicking biologic-shell based versus polymeric-shell nanoparticles for enhanced oral insulin delivery24
Publisher's Note24
Development and preclinical evaluation of a novel FGFR3-targeted antibody-drug conjugate in bladder cancer24
Advanced strategies of covalent organic framework nanomedicines in targeting and overcoming biological barriers23
Blockade of neutrophil recruitment to tumor sites based on sialic acid-modified nanoplatforms enhances the efficacy of checkpoint blockade immunotherapy23
Immunotherapeutic hydrogel for co-delivery of STAT3 siRNA liposomes and lidocaine hydrochloride for postoperative comprehensive management of NSCLC in a single application22
Preliminary delivery efficiency prediction of nanotherapeutics into crucial cell populations in bone marrow niche22
Neutrophil-targeted liposomal platform: A shift in novel approach for early detection and treatment of cancer metastasis22
Optimize the combination regimen of Trastuzumab and Nab-paclitaxel in HER2-positive tumors via modulating Caveolin-1 expression by lovastatin22
Electrically conductive “SMART” hydrogels for on-demand drug delivery22
Therapeutic potential of exosome‐based personalized delivery platform in chronic inflammatory diseases22
0.033190011978149